2025-02-27 Exercise | 2025-03-03 7:02 pm | 2024-07-09 2026-07-09 | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director | 3,223,726 | $0 | 4,575,556 (Indirect) | View |
2025-02-27 Exercise | 2025-03-03 7:02 pm | N/A N/A | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director | 353,249 | $0.9306 | 4,575,556 (Indirect) | View |
2025-02-27 Option Award | 2025-03-03 7:02 pm | N/A N/A | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director | 2,517,228 | $0 | 4,575,556 (Indirect) | View |
2024-09-17 Conversion | 2024-09-17 6:16 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Members of 10% Group 10% Owner | 16,809,237 | $0 | 897,587 (Indirect) | View |
Ownership | 2024-09-12 9:07 pm | N/A N/A | Bicara Therapeutics Inc. | BCAX | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 1,725,174 (Indirect) | View |
2024-07-15 Exercise | 2024-07-17 6:09 pm | N/A N/A | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director | 5,894,766 | $0 | 9,033,963 (Indirect) | View |
2024-07-09 Option Award | 2024-07-11 6:47 pm | N/A 2027-01-28 | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director 10% Owner | 41,794,350 | $0 | 41,794,350 (Indirect) | View |
2024-03-15 Option Award | 2024-03-19 9:39 pm | N/A N/A | BiomX Inc. | PHGE | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Mgmt HIF L.P. Deerfield Private Design Fund V L.P. Deerfield Healthcare Innovations Fund II L.P. *Director by Deputization Director 10% Owner | 3,162,729 | $0 | 3,189,709 (Indirect) | View |
2022-05-10 Conversion | 2022-05-10 6:22 pm | N/A N/A | PepGen Inc. | PEPG | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. Possible Member of 10% Group 10% Owner | 815,106 | $0 | 476,813 (Indirect) | View |
Ownership | 2022-05-05 8:00 pm | N/A N/A | PepGen Inc. | PEPG | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Deerfield Private Design Fund V L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 536,960 (Indirect) | View |
2021-10-26 Conversion | 2021-10-28 7:15 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. Possible Member of 10% Group 10% Owner | 15,129,450 | $0 | 1,143,972 (Indirect) | View |
Ownership | 2021-10-21 9:36 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | Flynn James E Deerfield Mgmt L.P. DEERFIELD PARTNERS L.P. DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) Deerfield Mgmt V L.P. *Possible Member of 10% Group 10% Owner | 0 | $0 | 1,512,944 (Indirect) | View |